https://scholars.lib.ntu.edu.tw/handle/123456789/612552
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Kim R.D. | en_US |
dc.contributor.author | Sarker D. | en_US |
dc.contributor.author | Meyer T. | en_US |
dc.contributor.author | Yau T. | en_US |
dc.contributor.author | Macarulla T. | en_US |
dc.contributor.author | Park J.-W. | en_US |
dc.contributor.author | Choo S.P. | en_US |
dc.contributor.author | Hollebecque A. | en_US |
dc.contributor.author | Sung M.W. | en_US |
dc.contributor.author | Lim H.-Y. | en_US |
dc.contributor.author | Mazzaferro V. | en_US |
dc.contributor.author | Trojan J. | en_US |
dc.contributor.author | Zhu A.X. | en_US |
dc.contributor.author | Yoon J.-H. | en_US |
dc.contributor.author | Sharma S. | en_US |
dc.contributor.author | ZHONG-ZHE LIN | en_US |
dc.contributor.author | Chan S.L. | en_US |
dc.contributor.author | Faivre S. | en_US |
dc.contributor.author | Feun L.G. | en_US |
dc.contributor.author | Yen C.-J. | en_US |
dc.contributor.author | Dufour J.-F. | en_US |
dc.contributor.author | Palmer D.H. | en_US |
dc.contributor.author | Llovet J.M. | en_US |
dc.contributor.author | Manoogian M. | en_US |
dc.contributor.author | Tugnait M. | en_US |
dc.contributor.author | Stransky N. | en_US |
dc.contributor.author | Hagel M. | en_US |
dc.contributor.author | Kohl N.E. | en_US |
dc.contributor.author | Lengauer C. | en_US |
dc.contributor.author | Sherwin C.A. | en_US |
dc.contributor.author | Schmidt-Kittler O. | en_US |
dc.contributor.author | Hoeflich K.P. | en_US |
dc.contributor.author | Shi H. | en_US |
dc.contributor.author | Wolf B.B. | en_US |
dc.contributor.author | Kang Y.-K. | en_US |
dc.date.accessioned | 2022-06-10T06:10:56Z | - |
dc.date.available | 2022-06-10T06:10:56Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 2159-8274 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075943998&doi=10.1158%2f2159-8290.CD-19-0555&partnerID=40&md5=6ae9258a7fde1efd3ed825e0be1be41d | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/612552 | - |
dc.publisher | American Association for Cancer Research Inc. | - |
dc.relation.ispartof | Cancer Discovery | - |
dc.title | First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1158/2159-8290.CD-19-0555 | - |
dc.identifier.pmid | 31575541 | - |
dc.identifier.scopus | 2-s2.0-85075943998 | - |
dc.relation.pages | 1696-1707 | - |
dc.relation.journalvolume | 9 | - |
dc.relation.journalissue | 12 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Medical Service-NTUCC | - |
crisitem.author.dept | Medical Oncology-NTUCC | - |
crisitem.author.dept | Center for Quality Management and Infection Control-NTUCC | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。